Transplantation of PI3Kδ inhibitor pre-treated CD8+ T-cells into B16 melanoma-bearing WT mice, resulted in a better tumor control (138, 143), which could be further enhanced by vaccination with the tumor antigen (138). The gene discussed is CD8A; the disease is neoplasm.